Results 131 to 140 of about 2,887 (179)

Comparative efficacy and safety of dual-combination vs. triple-combination antihypertensive therapies in hypertensive patients: an updated meta-analysis of randomized controlled trials. [PDF]

Front Pharmacol
Gong Z, Huang L, Long X, Zhang Y.
europepmc   +1 more source

Formulation and evaluation of liquisolid compacts for olmesartan medoxomil. [PDF]

J Drug Deliv, 2013
Prajapati ST, Bulchandani HH, Patel DM, Dumaniya SK, Patel CN.   +4 more
europepmc   +1 more source

Frequency and Profiles of Drug Combinations Constituting the Triple Whammy in Japan: An Analysis of a Patient Estimation Database. [PDF]

Pharmacy (Basel)
Maese M, Ito N, Shiokawa H, Kondo S, Okamoto Y, Iwata H, Urushibata S, Yamaura K.   +7 more
europepmc   +1 more source

Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial. [PDF]

Am J Cardiovasc Drugs, 2016
Sohn IS, Kim CJ, Oh BH, Hong TJ, Park CG, Kim BS, Chung WB, Investigators.   +7 more
europepmc   +1 more source

Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial. [PDF]

Am J Cardiovasc Drugs, 2016
Sohn IS, Kim CJ, Oh BH, Hong TJ, Park CG, Kim BS, Chung WB, Investigators.   +7 more
europepmc   +1 more source

Impact of the national centralized volume-based procurement policy on antihypertensive drug procurement, price, and volume in Guangxi: an interrupted time series analysis of procurement data. [PDF]

Front Pharmacol
Liang S, Zhang S, Li L, Luo J, Jiang L, Xian J.   +5 more
europepmc   +1 more source

A thorough QTc study demonstrates that olmesartan medoxomil does not prolong the QTc interval. [PDF]

J Clin Pharmacol, 2016
Mendell J, Matsushima N, O'Reilly TE, Lee J.   +3 more
europepmc   +1 more source

Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis. [PDF]

Drug Des Devel Ther, 2015
Sievers P, Uhlmann L, Korkmaz-Icöz S, Fastner C, Bea F, Blessing E, Katus HA, Preusch MR.   +7 more
europepmc   +1 more source

Development and Evaluation of a Modified Fixed-Dose Combination Antihypertensive Tablet Containing S-Amlodipine Besylate: A Bioequivalence and Stability Study. [PDF]

Pharmaceutics
Moon HW, Jeong JH, Park CW.
europepmc   +1 more source

Antihypertensive drug use for hypertensive disorders of pregnancy in hospitals across nine Chinese cities: a real-world data study. [PDF]

BMC Pregnancy Childbirth
Zhu Z, Tang Y, Lv J, Wang X.
europepmc   +1 more source